Atrial Fibrillation Market Share, Size, Definition, Treatment,
1 / 3

Atrial Fibrillation Market Share, Size, Definition, Treatment, Symptoms, Pipeline Review, H2 2016 - PowerPoint PPT Presentation

  • Uploaded on

Global Markets Direct\'s, \'Atrial Fibrillation - Pipeline Review, H1 2016\', provides an overview of the Atrial Fibrillation pipeline landscape.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'Atrial Fibrillation Market Share, Size, Definition, Treatment, Symptoms, Pipeline Review, H2 2016' - marketresearchri

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Atrial Fibrillation Market Share, Size, Definition, Treatment,

Symptoms, Causes, Pipeline Review, H2 2016


Global Markets Direct's, 'Atrial Fibrillation - Pipeline Review, H1 2016', provides an overview of the Atrial

Fibrillation pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Atrial Fibrillation,

complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration

(RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its

complete research and development history and latest news and press releases. Additionally, the report provides

an overview of key players involved in therapeutic development for Atrial Fibrillation and features dormant and

discontinued projects.

Browse Full Report with TOC @


Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and

nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's

proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor

presentations and featured press releases from company/university sites and industry-specific third party sources.

Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that

all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes

ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision

making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.


- The report provides a snapshot of the global therapeutic landscape of Atrial Fibrillation

- The report reviews pipeline therapeutics for Atrial Fibrillation by companies and universities/research institutes

based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till

discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description,

descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved Atrial Fibrillation therapeutics and enlists all their major and minor


- The report assesses Atrial Fibrillation therapeutics based on drug target, mechanism of action (MoA), route of

administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news related to pipeline therapeutics for Atrial Fibrillation

Reasons to Buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain

competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Atrial Fibrillation

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Atrial Fibrillation pipeline depth and focus of

Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most

attractive projects to enhance and expand business potential and Scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove

them from pipeline

Buy a Sample copy of This Report @


Table of Contents

Table of Contents 2

List of Tables 6

List of Figures 7

Introduction 8

Global Markets Direct Report Coverage 8

Atrial Fibrillation Overview 9

Therapeutics Development 10

Pipeline Products for Atrial Fibrillation - Overview 10

Pipeline Products for Atrial Fibrillation - Comparative Analysis 11

Atrial Fibrillation - Therapeutics under Development by Companies 12

Atrial Fibrillation - Therapeutics under Investigation by Universities/Institutes 13

Atrial Fibrillation - Pipeline Products Glance 14

Late Stage Products 14

Clinical Stage Products 15

Early Stage Products 16

Atrial Fibrillation - Products under Development by Companies 17

Atrial Fibrillation - Products under Investigation by Universities/Institutes 19

Atrial Fibrillation - Companies Involved in Therapeutics Development 20

ARCA biopharma, Inc. 20

AstraZeneca Plc 21

Bristol-Myers Squibb Company 22

Cardiome Pharma Corp. 23

Daiichi Sankyo Company, Limited 24

Gilead Sciences, Inc. 25

Ionis Pharmaceuticals, Inc. 26

Laboratoires Pierre Fabre SA 27

Nissan Chemical Industries, Ltd. 28

Nyken B.V. 29 Fibrillation therapeutics and enlists all their major and minor

Otsuka Holdings Co., Ltd. 30

Browse Full Report with TOC @


About Us:

Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence

requirements. We assist and facilitate organizations and individuals procure market research reports, helping them

in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries

and a host of micro markets. In addition to over extensive database of reports, our experienced research

coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research


Contact Details:

Michelle Thoras

Corporate Sales Specialist, USA

Radiant Insights, Inc

28 2nd Street,

Suite 3036 San Francisco,

CA 94105 United States

Phone: 1-415-349-0054

Toll Free: 1-888-202-9519


Email: [email protected]

Visit our Blog: